Authors: I. Lochman 1,2,*; V. Thon 2,3,4; J. Kratochvíla 5 Authors‘ workplace: Spadia Lab, Ostrava 1; Ústav laboratorní medicíny lékařské fakulty OU, Ostrava 2; RECETOX, Přírodovědecká fakulta, Masarykova univerzita, Brno 3; AKIMED, Brno 4; SEKK, Pardubice 5 Published in: Klin. Biochem. Metab., 31, 2023, No. 2, p. 37-47 doi: https://doi.org/10.61568/kbm.2023.010
In this work, the authors would like to share their experience in laboratory diagnostics and in the care of individuals affected by SARS-CoV-2 infection and in the early stages of the disease of COVID-19 that this infection can cause. It is based on the results of tests that were carried out in the laboratories of Spadia Lab Ostrava during the gradual introduction and internal verification of laboratory methods in the diagnosis of this infection into routine practice, on the experience of caring for such individuals in the AKIMED Brno outpatient clinic and the knowledge obtained with them from the available literature on this issue. The author's opinions on the current state of laboratory diagnosis of this infection and the disease caused by it and the possibility of streamlining the care of people affected by this infection and the disease, especially in their early stages, are presented for discussion, even though they are aware that their set of people on whom the data was for the study obtained is small and limiting. The full English version of the article is available here [1].
COVID-19 – SARS-Cov-2 infection – laboratory diagnostics – humoral and cellular immunity
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
